GlassScriptPhysician profile
Stephen Thomas Melnick
NPI 1497132641
$6,931.01
in general payments reported to CMS, 2019-2025
15 companies · $2,003 in 2025
The $2,003 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.65 · 2020: $16.72 · 2021: $628 · 2022: $2,831 · 2023: $730 · 2024: $638 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Travel and Lodging: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,232.77 |
| Travel and Lodging | $1,138.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,479.22 | 2021-2025 | Aveir, Ensite Precision, Pressurewire |
| Biotronik INC. | $1,862.34 | 2022 | |
| Boston Scientific Corporation | $454.21 | 2024-2025 | Rhythmia Mapping System, General - Therapies, Farapulse |
| Medtronic, INC. | $397.22 | 2021-2023 | Linq II |
| Atricure, INC. | $314.28 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Philips North America LLC | $110.86 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $90.42 | 2019-2023 | Farxiga |
| Amgen INC. | $47.07 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $37.40 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.25 | 2019-2024 | Lifevest |
| Chiesi USA, INC. | $32.18 | 2022 | |
| Biosense Webster, INC. | $24.49 | 2023 | Carto 3 |
| Cordis US Corp. | $21.26 | 2025 | Mynx Control Venous |
| Pfizer INC. | $13.03 | 2021 | |
| W. L. Gore & Associates, INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Melnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.